Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-K, Date: 2013-04-01, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: SKBI/20130401/10-K_1/1/000.htm SEC Original: v338149_10k.htm
TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K FOR YEAR ENDED DECEMBER 31, 2012 Page PART I Item 1. Business 2 Item 1A. Risk Factors 10 Item 1B. Unresolved Staff Comments 19 Item 2. Properties 19 Item 3. Legal Proceedings 20 Item 4. Mine Safety Disclosures 21 PART II Item 5. 21 Item 7. Management’s Discussion and Analysis of

---

---

Webplus: SKBI/20130401/10-K_1/4_EX-31.1/000.htm SEC Original: v338149_ex31-1.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20130401/10-K_1/5_EX-31.2/000.htm SEC Original: v338149_ex31-2.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: SKBI/20130401/10-K_1/6_EX-32.1/000.htm SEC Original: v338149_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. April 1, 2013 Weibing Lu Chief Executive Officer

---

---

Webplus: SKBI/20130401/10-K_1/7_EX-32.2/000.htm SEC Original: v338149_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. April 1, 2013 Bing Mei Chief Financial Officer

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-K, Date: 2013-04-01, XBRL Interactive FinancialsCIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE